Novozymes welcomes enzyme patent ruling

By staff reporter

- Last updated on GMT

Related tags Patent Patent application Novozymes

Novozymes has welcomed last week's court ruling over a disputed
enzyme patent, saying that it was 'very pleased with the decision'.

The judge concluded the case last week, saying that "... the defendants have infringed claims 1, 3 and 5 of the 031 patent, that those claims are valid, and that the 031 patent is enforceable.

"Accordingly, this case will proceed to the second phase trial to decide the issues of willfulness and damages."

But despite the positive outcome, Novozymes claims that the patent infringement has caused the firm problems.

"Its very satisfactory that the court agreed that our patent is valid and has been infringed, considering the large amount of resources we use on research, development and patenting,"​ said Novozymes general counsel Kristian Merser.

The case, between Novozymes and Danisco, lasted 1, years and concerned an infringement of one of Novozymes patents on enzymes for bioethanol.

Novozymes claimed in 2004 that Genencor International - later bought by Danisco - was selling enzymes protected by Novozymes patent rights on the booming US ethanol market.

Danisco division Genencor has now voluntarily withdrawn its Spezyme Ethyl product from the market. The company said last week that legal options are currently being reviewed and that appeal of the ruling is being considered.

"Overall, this court ruling will not materially affect Daniscos enzyme business including the ethanol segment,"​ said CEO Tom Knutzen.

"The product withdrawn is just one of a full product range for the ethanol segment, which covers both the traditional ethanol production process and the 'no-cook' process, for which Genencor launched the Stargen 001 product in 2005."

The size of the damages will be decided this autumn. Novozymes has claimed several million US dollars in damages for loss of profits.

Related news

Show more

Related products

Alternative dairy innovation

Alternative dairy innovation

Lallemand Bio-Ingredients | 21-Oct-2022 | Technical / White Paper

Lallemand Bio-Ingredients offers an elaborate portfolio of specialty ingredients to help address the many challenges surrounding alternative dairy products.

Enhancing freeze-drying survival rate

Enhancing freeze-drying survival rate

Angel Yeast – Fermentation Nutrition | 02-Sep-2022 | Technical / White Paper

Angel Yeast has concluded that nucleic acids in yeast extract have significant positive effect on improving the biomass and survival rate of Lactobacillus...

Writing a brief for an ingredient supplier

Writing a brief for an ingredient supplier

BIOSPRINGER, natural Yeast ingredients | 04-Feb-2022 | Application Note

Finding an ingredient supplier can be time consuming and requires technical skills to consider the many criteria. At Biospringer, we have developed, in...

Related suppliers

Follow us


View more